Literature DB >> 17986816

Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part I.

Pauline Aalten1, Frans R J Verhey, Marina Boziki, Roger Bullock, Eleanor Jane Byrne, Vincent Camus, Miriam Caputo, Debby Collins, Peter Paul De Deyn, Kazi Elina, Giovanni Frisoni, Nicola Girtler, Clive Holmes, Catherine Hurt, Anna Marriott, Patrizia Mecocci, Flavio Nobili, Pierre Jean Ousset, Emma Reynish, Eric Salmon, Magda Tsolaki, Bruno Vellas, Philippe H Robert.   

Abstract

BACKGROUND/AIMS: The aim of this study was to identify neuropsychiatric subsyndromes of the Neuropsychiatric Inventory in a large sample of outpatients with Alzheimer's disease (AD).
METHODS: Cross-sectional data of 2,354 patients with AD from 12 centres from the European Alzheimer's Disease Consortium were collected. Principal component analysis was used for factor analysis.
RESULTS: The results showed the presence of 4 neuropsychiatric subsyndromes: hyperactivity, psychosis, affective symptoms and apathy. The subsyndrome apathy was the most common, occurring in almost 65% of the patients.
CONCLUSION: This large study has provided additional robust evidence for the existence of neuropsychiatric subsyndromes in AD. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 17986816     DOI: 10.1159/000110738

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  85 in total

1.  Relearning of Activities of Daily Living: A Comparison of the Effectiveness of Three Learning Methods in Patients with Dementia of the Alzheimer Type.

Authors:  J Bourgeois; M Laye; J Lemaire; E Leone; A Deudon; N Darmon; C Giaume; V Lafont; S Brinck-Jensen; A Dechamps; A König; P Robert
Journal:  J Nutr Health Aging       Date:  2016-01       Impact factor: 4.075

2.  An initial study of modifiable and non-modifiable factors for late-life psychosis.

Authors:  Obiora E Onwuameze; Susan K Schultz; Sergio Paradiso
Journal:  Int J Psychiatry Med       Date:  2011       Impact factor: 1.210

3.  Proinflammatory cytokines, sickness behavior, and Alzheimer disease.

Authors:  C Holmes; C Cunningham; E Zotova; D Culliford; V H Perry
Journal:  Neurology       Date:  2011-07-13       Impact factor: 9.910

Review 4.  Aging society and gerontechnology: a solution for an independent living?

Authors:  A Piau; E Campo; P Rumeau; B Vellas; F Nourhashémi
Journal:  J Nutr Health Aging       Date:  2014-01       Impact factor: 4.075

5.  Symptom Clusters of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Their Comparative Risks of Dementia: A Cohort Study of 8530 Older Persons.

Authors:  Tau Ming Liew
Journal:  J Am Med Dir Assoc       Date:  2019-03-26       Impact factor: 4.669

6.  Neuropsychiatric symptoms in Alzheimer's disease are related to functional connectivity alterations in the salience network.

Authors:  Marcio L F Balthazar; Fabrício R S Pereira; Tátila M Lopes; Elvis L da Silva; Ana Carolina Coan; Brunno M Campos; Niall W Duncan; Florindo Stella; Georg Northoff; Benito P Damasceno; Fernando Cendes
Journal:  Hum Brain Mapp       Date:  2013-02-18       Impact factor: 5.038

Review 7.  Non-cognitive symptoms and related conditions in the Alzheimer's disease: a literature review.

Authors:  Francesco Raudino
Journal:  Neurol Sci       Date:  2013-03-31       Impact factor: 3.307

8.  Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer's disease.

Authors:  Paula T Trzepacz; Peng Yu; Phani K Bhamidipati; Brian Willis; Tammy Forrester; Linda Tabas; Adam J Schwarz; Andrew J Saykin
Journal:  Alzheimers Dement       Date:  2012-12-17       Impact factor: 21.566

9.  Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease.

Authors:  Paula T Trzepacz; Jeffrey Cummings; Thomas Konechnik; Tammy D Forrester; Curtis Chang; Ellen B Dennehy; Brian A Willis; Catherine Shuler; Linda B Tabas; Constantine Lyketsos
Journal:  Int Psychogeriatr       Date:  2012-12-21       Impact factor: 3.878

Review 10.  For whom and for what the definition of severe dementia is useful: an EDCON consensus.

Authors:  E J Byrne; M Benoit; J M Lopez Arrieta; C Geraldi; R Koopmans; Y Rolland; N Sartorius; G Stoppe; P Robert
Journal:  J Nutr Health Aging       Date:  2008-12       Impact factor: 4.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.